LABIANA HEALTH S.A.EO-10

Research LABIANA HEALTH S.A.EO-10 (8RK) on Bullrun: market cap EUR 51.78M, P/E 16.9. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker8RK
• ExchangeF
• CountrySpain
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyEUR
• Market capEUR 51.78M
• P/E16.9
• Financial periodFY2024
• RevenueEUR 66.26M
• Revenue growth13.3%
• Net incomeEUR 253.45K
• Free cash flowEUR 4.15M
• Gross margin61.8%

Valuation Snapshot

latest market cap is EUR 51.78M; P/E is 16.9.

About LABIANA HEALTH S.A.EO-10

Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms, bacterial vaccines and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name.

Frequently asked questions

What is LABIANA HEALTH S.A.EO-10's market cap?

LABIANA HEALTH S.A.EO-10's market capitalization is EUR 51.78M.

What is LABIANA HEALTH S.A.EO-10's P/E ratio?

LABIANA HEALTH S.A.EO-10's price-to-earnings (P/E) ratio is 16.9.

What does LABIANA HEALTH S.A.EO-10 do?

Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally.